// App-Quantinova.ai

TCT-67 : The First Establishment of Early Healing Profile, 9-month Neointimal Growth, and 24 Months Outcomes of the Dual Therapy Endothelial Progenitor Cell Capturing Sirolimus-eluting Stent as Assessed by Longitudinal Sequential Optical Coherence Tomography: The EGO-COMBO Study.

Researchers

Presenter

  • Stephen Wai Luen LEE

Principal Investigators

  • Simon C.C. LAM

  • Kelvin Ki Wan Chan

  • Shun Ling Kong

  • Chor Cheung Frankie Tam

  • Michael Ka Lam Wong

  • Anthony Yiu Tung Wong

  • Arthur See Yue Yung

  • Pak Hei Chan

Medical Centers

  • Mount Sinai Hospital, New York, NY

  • Cardiovascular Research Foundation and Columbia University Medical Center, New York, United States

  • Queen Mary Hospital, University of Hong Kong, Hong Kong, Hong Kong

  • Stadtische Kliniken Neuss, Lukaskrankenhaus GmbH

Locations

  • United States

  • Hong Kong

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Neoatherosclerosis

  • Angina

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • sirolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved